Decreased corneal opacity and improved vision in a patient with mucopolysaccharidosis I (Hurler-Scheie) treated with enzyme replacement therapy (laronidase, Aldurazyme).
Cáceres-Marzal
Cristina
C
Department of Pediatrics, University Children's Hospital, Badajoz, Spain. ccaceresmarzal@yahoo.es
García-Reymundo
Mercedes
M
Solana
Jorge
J
de Arévalo
Bernardo
B
Vaquerizo
Julián
J
Galán
Enrique
E
D000328:Adult; D003318:Corneal Opacity / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D006801:Humans; D007068:Iduronidase / Q000627:therapeutic use*; D008297:Male; D008059:Mucopolysaccharidosis I / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D014786:Vision Disorders / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D014792:Visual Acuity / Q000187:drug effects
D011994:Recombinant Proteins; D007068:Iduronidase